Trials / Recruiting
RecruitingNCT07016035
Translation and Validation of the French mPCOSQ (mPCOSQ-F).
Translation and Validation of the French Version of the Health-related Quality of Life Questionnaire for the Polycystic Ovary Syndrome: the mPCOSQ-F.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 350 (estimated)
- Sponsor
- CHU de Reims · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome. The first stage of the study consisted in translating the questionnaire from English to French. Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.
Detailed description
The aim of this study is to assess the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome. Women aged 18 to 45 years with a diagnosis of polycystic ovary syndrome will be included. The first stage of the study consisted in translating the questionnaire from English to French. Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again. The pre-test phase purpose is to appraise the face validity and feasibility of the questionnaire through phone interviews with the thirty first respondents. In the final phase, we aimed to evaluate the validity and reliability of the mPCOSQ, and to compare it to the SF-36.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | mPCOSQ-F and SF-36 | Questionnaires |
Timeline
- Start date
- 2025-05-12
- Primary completion
- 2027-05-12
- Completion
- 2027-05-12
- First posted
- 2025-06-11
- Last updated
- 2025-08-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07016035. Inclusion in this directory is not an endorsement.